NCT05685602 2026-03-19CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic CancerNational Cancer Institute (NCI)Phase 1 Recruiting43 enrolled
NCT05422794 2026-03-18Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast CancerNational Cancer Institute (NCI)Phase 1 Recruiting57 enrolled